Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

109 results about "Frameshift mutation" patented technology

A frameshift mutation (also called a framing error or a reading frame shift) is a genetic mutation caused by indels (insertions or deletions) of a number of nucleotides in a DNA sequence that is not divisible by three. Due to the triplet nature of gene expression by codons, the insertion or deletion can change the reading frame (the grouping of the codons), resulting in a completely different translation from the original. The earlier in the sequence the deletion or insertion occurs, the more altered the protein. A frameshift mutation is not the same as a single-nucleotide polymorphism in which a nucleotide is replaced, rather than inserted or deleted. A frameshift mutation will in general cause the reading of the codons after the mutation to code for different amino acids. The frameshift mutation will also alter the first stop codon ("UAA", "UGA" or "UAG") encountered in the sequence. The polypeptide being created could be abnormally short or abnormally long, and will most likely not be functional.

Wheat TaAGO4a gene CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats)/-CRISPR-associated protein 9) vector and application thereof

The invention provides a wheat TaAGO4a gene CRISPR / Cas9 (clustered regularly interspaced short palindromic repeats) / -CRISPR-associated protein 9) vector and application thereof and belongs to the field of crop molecular biology. The wheat TaAGO4a gene CRISPR / Cas9 vector and the application thereof have the advantages that gRNA of a third exon of specificity-targeted TaAGO4a is provided firstly, a DNA sequence of the gRNA is shown as SEQ ID NO.1, and the gRNA contains an enzyme cutting site XmnI; subsequently, the CRISPR / Cas9 vector containing the gRNA is provided, and through co-transformation of Cas9 and the specific gRNA into a wheat protoplast as well as enzyme cutting and sequencing technologies, the condition that the gRNA can guide the Cas9 to cut three copies positioned on a chromosome 3A, a chromosome 3B and a chromosome 3D of the TaAGO4a respectively can be detected successfully so as to cause frameshift mutation of the gene and result in afunction or excalation of the gene; the wheat TaAGO4a gene CRISPR / Cas9 vector can be used for preparing TaAGO4a gene-deleted transgenic wheat.
Owner:INST OF CROP SCI CHINESE ACAD OF AGRI SCI

Methods and materials for detecting frameshift mutations

The invention relates to methods and materials for detecting in a biological sample the presence or absence of a target protein having a frameshift mutation that results in missense amino acid sequence downstream of the frameshift mutation, comprising combining with the biological sample a binding ligand that is capable of specifically binding the missense amino acid sequence, and then determining whether the binding ligand binds to the missense amino acid sequence. Binding of the ligand to the missense amino acid sequence is indicative of the presence of the frameshift mutation.
Owner:GREAT BASIN SCI

Product for diagnosing congenital scoliosis and application of product

ActiveCN104328169AEarly intervention time is goodMicrobiological testing/measurementFrameshift mutationHaplotype
The invention discloses a product for diagnosing congenital scoliosis. According to the product, the judgment is carried by detecting whether a chromosome 16p11.2 is micro-deleted or the TBX6 gene frameshift mutation exists and according to the haplotypes of two SNP sites of rs3809624-rs3809627 in a TBX6 gene on another homologous chromosome. The diagnostic kit is sensitive and can be used for diagnosing the congenital scoliosis in early stage.
Owner:PEKING UNION MEDICAL COLLEGE HOSPITAL CHINESE ACAD OF MEDICAL SCI

Modification of the dystrophin gene and uses thereof

InactiveUS20180265859A1Restoring correct reading frameAvoid large deletionsOrganic active ingredientsSugar derivativesMuscular dystrophyFrameshift mutation
Methods of modifying a dystrophin gene are disclosed, for restoring dystrophin expression within a cell having an endogenous frameshift mutation within the dystrophin gene. The methods comprising introducing a first cut within an exon of the dystrophin gene creating a first exon end, wherein said first cut is located upstream of the endogenous frameshift mutation; and introducing a second cut within an exon of the dystrophin gene creating a second exon end, wherein said second cut is located downstream of the frameshift mutation. Upon joining / ligation of said first and second exon ends dystrophin expression is restored, as the correct reading frame is restored. Reagents and uses of the method are also disclosed, for example to treat a subject suffering from muscular dystrophy.
Owner:UNIV LAVAL

Carrier incapable of generating frameshift mutation after recombination as well as method and application for gene fixe-point knock-in in Xenopus laevis genome

The invention provides a carrier incapable of generating frameshift mutation after recombination as well as a method and an application for gene fixe-point knock-in in a Xenopus laevis genome. The method comprises steps as follows: (1), guide RNA (ribonucleic acid), Cas9 nuclease and a donor carrier with a pancreas ela-fluorescent screening label and a Cas9 target fragment are contained in a fertilized egg of Xenopus laevis; (2) under the joint action of guide RNA and Cas9 nuclease, a target gene in the Xenopus laevis genome and the double-chain Cas9 target fragment on the donor carrier are shorn; (3), gene fixed-point knock-in of the Xenopus laevis genome is realized through a DNA (deoxyribonucleic acid) recovery function of Xenopus laevis cells; (4), G0-generation embryos are screened through the pancreas ela-fluorescent screening label, and F1 is subjected to southern blot identification. The carrier incapable of generating frameshift mutation after recombination as well as the method and the application for gene fixe-point knock-in in the Xenopus laevis genome lay a foundation for research of genetics and human diseases with Xenopus laevis as a model animal.
Owner:GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI

HDAC8 gene knockout BHK-21 cell line as well as construction method and application thereof

The invention discloses a construction method of an HDAC8 gene knockout BHK-21 cell line, which comprises the following steps: carrying out gene knockout on HDAC8 in a cell line BHK-21 for foot-and-mouth disease vaccine production by utilizing a CRISPR/Cas9 technology, transfecting BHK-21 cells by utilizing CRISPR plasmids for knocking out the HDAC8, and performing separation to obtain a plurality of cell clones by utilizing antibiotic screening in combination with gradient dilution and a cloning ring method. After genome DNA is extracted, PCR amplification and sequencing are carried out, and cell clones of which two HDAC8 genes are subjected to homozygous frameshift mutation are successfully identified. In the HDAC8 knockout BHK-21 cell line, the replication rate of foot-and-mouth disease virus is obviously accelerated, the final virus titer is obviously improved, and the HDAC8 knockout has no obvious influence on the cell growth rate, which shows that the HDAC8 knockout BHK-21 cell line has the prospect of being used for foot-and-mouth disease vaccine production. A foundation is laid for further knocking out HDAC8 from suspension culture type BHK-21 cells and directly applying HDAC8 to production of foot-and-mouth disease vaccines.
Owner:LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI

Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2

Recombinant respiratory syncytial virus (RSV) are provided in which expression of the second translational open reading frame encoded by the M2 gene (M2ORF2) is reduced or ablated to yield novel RSV vaccine candidates. Expression of M2 ORF2 is reduced or ablated by modifying a recombinant RSV genome or antigenome to incorporate a frame shift mutation, or one or more stop codons in M2 ORF2. Alternatively, M2 ORF2 is deleted in whole or in part to render the M2-2 protein partially or entirely non-functional or to disrupt its expression altogether. M2 ORF2 deletion and knock out mutants possess highly desirable phenotypic characteristics for vaccine development. These changes specify one or more desired phenotypic changes in the resulting virus or subviral particle. Vaccine candidates are generated that show a change in mRNA transcription, genomic or antigenomic RNA replication, viral growth characteristics, viral antigen expression, viral plaque size, and / or a change in cytopathogenicity. In addition, M2-2 knock out or deletion virus exhibits increased levels of synthesis of viral proteins in cell culture, providing an enriched source of viral antigen or protein for purification and use as a noninfectious subunit vaccine.
Owner:UNITED STATES OF AMERICA

HDAC3 gene knockout BHK-21 cell line as well as construction method and application thereof

The invention discloses a construction method of an HDAC3 gene knockout BHK-21 cell line, which comprises the following steps: carrying out gene knockout on HDAC3 in a cell line BHK-21 for foot-and-mouth disease vaccine production by utilizing a CRISPR/Cas9 technology, transfecting BHK-21 cells by utilizing CRISPR plasmids for knocking out the HDAC3, and separating the cells to obtain a plurality of cell clones by utilizing antibiotic screening in combination with gradient dilution and a cloning ring method; extracting the genome DNA, performing PCR amplification and sequencing, and successfully identifying the cell clones of which two HDAC3 genes are subjected to homozygous frameshift mutation. In the HDAC3 knockout BHK-21 cell line, the replication rate of foot-and-mouth disease virus is obviously accelerated, the final virus titer is obviously improved, and the HDAC3 knockout has no obvious influence on the cell growth rate, so that the HDAC3 knockout BHK-21 cell line has the prospect of being used for foot-and-mouth disease vaccine production. Therefore, the foundation is laid for further knocking out HDAC3 from suspension culture type BHK-21 cells and directly applying HDAC3 to foot-and-mouth disease vaccine production.
Owner:LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI

HDAC5 gene knockout BHK-21 cell line as well as construction method and application thereof

The invention discloses a construction method of an HDAC5 gene knockout BHK-21 cell line, which comprises the following steps: carrying out gene knockout on HDAC5 in a cell line BHK-21 for foot-and-mouth disease vaccine production by utilizing a CRISPR/Cas9 technology, transfecting BHK-21 cells by utilizing CRISPR plasmids for knocking out the HDAC5, and separating the cells to obtain a plurality of cell clones by utilizing antibiotic screening in combination with gradient dilution and a cloning ring method; extracting the genome DNA, performing PCR amplification and sequencing and successfully identifying the cell cloning of which one HDAC5 gene is subjected to homozygous frameshift mutation, wherein the HDAC5-KO-A2 has deletion of 13 basic groups at a Cas9 predetermined cutting position. In the HDAC5 knockout BHK-21 cell line, the replication rate of foot-and-mouth disease virus is obviously accelerated, the final virus titer is obviously improved, and the HDAC5 knockout has no obvious influence on the cell growth rate, so that the HDAC5 knockout BHK-21 cell line has the prospect of being used for foot-and-mouth disease vaccine production. Therefore, the foundation is laid for further knocking out HDAC5 from suspension culture type BHK-21 cells and directly applying HDAC5 to production of foot-and-mouth disease vaccines.
Owner:LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI

Method for cultivating new variety of normal-development intermuscular-bone-free fish

ActiveCN112772468AGenetic stabilitySolve small, hard-to-find, hard-to-kick puzzlesClimate change adaptationPisciculture and aquariaZooidMating
The invention relates to a method for cultivating a new variety of normal-development intermuscular-bone-free fish, and relates to a method for cultivating a new variety of intermuscular-bone-free fish. The invention provides the method for removing intermuscular bones under the condition that normal growth of fishes is not influenced. The method for cultivating the new variety of the normal-development intermuscular-bone-free fish comprises the following steps of 1, knocking out a bmp6 gene in a fertilized egg of an original fish variety to obtain an F0-generation individual; 2, performing mutant screening on the F0 generation, and matching to obtain an F1 generation population; 3, performing mutant screening on the F1 generation population, selecting individuals with the same frameshift mutation for mating, constructing an F2 generation, and screening out homozygous mutation individuals in the F2 generation; and 4, propagating the F2-generation homozygous mutation individuals to obtain the new variety of the intermuscular-bone-free fish. According to the method, a strain with intermuscular bones deleted can be obtained, growth is not affected, stable inheritance can be achieved, and the problems that the intermuscular bones are small, difficult to find and difficult to remove in production can be solved.
Owner:HEILONGJIANG RIVER FISHERY RES INST CHINESE ACADEMY OF FISHERIES SCI

HDAC2 gene knockout BHK-21 cell line as well as construction method and application thereof

The invention discloses a construction method of an HDAC2 gene knockout BHK-21 cell line. The construction method comprises the following steps: carrying out gene knockout on HDAC2 in a cell line BHK-21 for foot-and-mouth disease vaccine production by utilizing a CRISPR/Cas9 technology; the inventor transfects BHK-21 cells with CRISPR plasmids for knocking out HDAC2, and then separates a plurality of cell clones by using a cloning ring method by combining antibiotic screening with gradient dilution; after genome DNA is extracted, PCR amplification and sequencing are carried out, and cell cloning of which one HDAC2 gene is subjected to homozygous frameshift mutation is successfully recognized; wherein the HDAC2-KO-B3 has the deletion of one basic group at the predetermined cutting position of the Cas9. In the BHK-21 cell line with HDAC2 knockout, the replication rate of foot-and-mouth disease virus is obviously accelerated, the final virus titer is obviously improved, and the cell growth rate is not obviously influenced after HDAC2 knockout, so that the HDAC2 knockout BHK-21 cell line has the prospect of being used for foot-and-mouth disease vaccine production. A foundation is laid for further knocking out HDAC2 from suspension culture type BHK-21 cells and directly applying HDAC2 to production of foot-and-mouth disease vaccines.
Owner:LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI

Pseudorabies virus gene deleted strain, inactivated vaccine for porcine pseudorabies, and preparation method and application of inactivated vaccine

The invention discloses a pseudorabies virus gene deleted strain, and a preparation method of an inactivated vaccine for porcine pseudorabies. The gene deleted strain is a pseudorabies virus gE gene deleted strain, which is constructed through reading frame frameshift mutation caused by deletion of a plurality of basic groups from a wild-type pseudorabies virus (PRV) strain gE gene sequence. The preparation method includes the following steps: constructing the pseudorabies virus gE gene deleted strain; domesticating a porcine testicular cell and subjecting the same to suspension culture; inoculating the porcine testicular cell with the pseudorabies virus gE gene deleted strain, and harvesting a cell culture when 80-90% of the cell has lesions to obtain cell venom containing supernatant; taking the supernatant to measure the valence, and inactivating the qualified cell venom in a sterilization container; and mixing the inactivated cell venom with an adjuvant to obtain the inactivated vaccine for the porcine pseudorabies. The prepared inactivated vaccine for the porcine pseudorabies has high immunogenicity, long immunization period, and no side effects after immunization, is safe andreliable, and can effectively prevent infections of pseudorabies virus epidemic strains.
Owner:SHANGHAI ACAD OF AGRI SCI +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products